SandlerResearch

Osteoarthritis - Pipeline Assessment and Market Forecasts to 2017 Now Available at SandlerResearch

 

Dallas, TX -- (SBWIRE) -- 11/24/2010 -- SandlerResearch announce it will carry Osteoarthritis - Pipeline Assessment and Market Forecasts to 2017 Market Research Report in its Store.

GlobalData, the industry analysis specialist’s new report, “Osteoarthritis - Pipeline Assessment and Market Forecasts to 2017” is an essential source of information and analysis on the global osteoarthritis therapeutics market. The report identifies the key trends shaping and driving the global osteoarthritis therapeutics market.

The report also provides insight on the competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global osteoarthritis therapeutics market.

Scope
- Annualized global osteoarthritis therapeutics market revenues data from 2001 to 2009, forecast forward for 7 years to 2017.

- Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.

- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. The first-in-class drugs act through new mechanisms of action such as Nuclear Factor-KappaB (NF-kB) activation inhibitors, TNF alpha blockers, cannabinoid receptor (CB2) agonists and protease inibitors.

- Analysis of the current and future market competition in the global osteoarthritis therapeutics. Key future market players covered are Pfizer, Novartis AG, J&J and Crystalgenomics.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with osteoarthritis therapeutics market.

Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global osteoarthritis therapeutics market.

- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global osteoarthritis therapeutics market in future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- What’s the next big thing in the global osteoarthritis therapeutics market landscape? – Identify, understand and capitalize.

Browse complete Report on: Osteoarthritis - Pipeline Assessment and Market Forecasts to 2017
http://www.sandlerresearch.org/reports/41248-osteoarthritis-pipeline-assessment-and-market-forecasts-to-2017.html

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Osteoarthritis: Introduction 5
2.1 Overview 5
2.2 GlobalData Pipeline Report Guidance 6
3 Osteoarthritis Therapeutics Market: Market Characterization 7
3.1 Osteoarthritis Market Forecast and CAGR 8
3.2 Drivers and Barriers for the Osteoarthritis Therapeutics Market 10
3.2.1 Drivers for the Osteoarthritis Therapeutics Market 10
3.2.2 Barriers for the Osteoarthritis Therapeutics Market 10
3.3 Opportunity and Unmet Need 11
3.4 Key Takeaway 12
4 Osteoarthritis Therapeutics Market: Competitive Assessment 13
4.1 Overview 13
4.2 Strategic Competitor Assessment 13
4.3 Product Profiles of the Major Marketed Products in the Osteoarthritis Therapeutics Market 14
4.3.1 Celebrex (Celecoxib) 14
4.3.2 Mobic (meloxicam) 15
4.3.3 Voltaren Gel (diclofenac sodium) 15
4.3.4 Hyalgan (sodium hyaluronate) 16
4.3.5 Ultram ER (tramadol extended release) 16
4.4 Key Takeaway 17
5 Osteoarthritis Therapeutics Market: Pipeline Assessment 18
5.1 Overview 18
5.2 Strategic Pipeline Assessment 18
5.2.1 Technology Trends Analytic Framework 18
5.3 Osteoarthritis Therapeutics – Promising Drugs under Clinical Development 19
5.4 Molecule Profile for Promising Drugs under Clinical Development 20
5.4.1 SD6010 20
5.4.2 CG100649 21
5.5 OA Market – Clinical Pipeline by Mechanism of Action 22
5.6 Osteoarthritis Pipeline – Pipeline by Clinical Phases of Development 23
5.6.1 Osteoarthritis Therapeutics – Phase III Clinical Pipeline 24
5.6.2 Osteoarthritis Therapeutics – Phase II Clinical Pipeline 25
5.6.3 Osteoarthritis Therapeutics – Phase I Clinical Pipeline 26
5.6.4 OA Therapeutics – Pre-clinical Pipeline 27
5.6.5 Osteoarthritis Therapeutics – Discovery Pipeline 27
5.6.6 Osteoarthritis Therapeutics – Discontinued Pipeline 28
5.7 Key Takeaway 28
6 Osteoarthritis Market: Implications for Future Market Competition 29
7 Osteoarthritis Market: Future Players in the Osteoarthritis Market 30
7.1 Introduction 30
7.2 Novartis Pharma AG (Novartis) 31
7.2.1 Overview 31
7.2.2 Osteoarthritis Disease Portfolio 31
7.2.3 SMC021 31
7.3 Pfizer Inc. 32
7.3.1 Overview 32
7.3.2 Osteoarthritis Disease Portfolio 33
7.3.3 SD6010 33
7.4 Johnson and Johnson 33
7.4.1 Company Overview 33
7.4.2 Osteoarthritis Disease Portfolio 34
7.5 CrystalGenomics, Inc. 34
7.5.1 Company Overview 34
7.5.2 Osteoarthritis Disease Portfolio 34
7.5.3 CG100649 35
8 Osteoarthritis Therapeutics Market: Appendix 36
8.1 Definitions 36
8.2 Acronyms 36
8.3 Research Methodology 37
8.3.1 Coverage 37
8.3.2 Secondary Research 38
8.3.3 Forecasting 38
8.3.4 Primary Research 41
8.3.5 Expert Panel Validation 41
8.4 Contact Us 41
8.5 Disclaimer 41
8.6 Sources 42

Browse all Healthcare Market Research Reports on:
http://www.sandlerresearch.org/market-research/healthcare/

Browse all GlobalData Market Research Reports on:
http://www.sandlerresearch.org/publishers/globaldata/

Browse all Newly Published Market Research Reports on:
http://www.sandlerresearch.org/LatestReport.aspx

Related Reports:
Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017
http://www.sandlerresearch.org/reports/36584-influenza-vaccines-pipeline-assessment-and-market-forecasts-to-.html

Acute Myeloid Leukemia (AML) - Pipeline Assessment and Market Forecasts to 2017
http://www.sandlerresearch.org/reports/39673-acute-myeloid-leukemia-aml-pipeline-assessment-and-market-for.html

Head and Neck Cancer - Pipeline Assessment and Market Forecast to 2017
http://www.sandlerresearch.org/reports/36585-head-and-neck-cancer-pipeline-assessment-and-market-forecast-to.html

Rheumatoid Arthritis - Pipeline Assessment and Market Forecasts to 2017
http://www.sandlerresearch.org/reports/37160-rheumatoid-arthritis-pipeline-assessment-and-market-forecasts-t.html

Systemic Lupus Erythematosus - Pipeline Assessment and Market Forecasts to 2017
http://www.sandlerresearch.org/reports/37161-systemic-lupus-erythematosus-pipeline-assessment-and-market-for.html

About Sandler Research
Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe.
Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.

We also provide 24/7 online and offline support to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.sandlerresearch.com